Cockayne Syndrome Type II Clinical Trials

• Examination of Clinical and Laboratory Abnormalities in Patients with Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
  ClinicalTrials.gov Identifier: NCT00001813 - Recruiting
  Cockayne Syndrome; Skin Neoplasm; Xeroderma Pigmentosum
  
• Prospective Study of Patients with Hirsutism
  ClinicalTrials.gov Identifier: NCT00145288 - Active, not recruiting
  Hirsutism; Type 2 Diabetes; Polycystic Ovary Syndrome
  
• Celiprolol in Patients With Ehlers-Danlos Syndrome, Vascular Type
  ClinicalTrials.gov Identifier: NCT00190411 - Active, not recruiting
  Ehlers-Danlos Syndrome, Type Iv, Autosomal Dominant; Gene Map Locus 2q31
  
• Body Composition, Glucose Metabolism, Insulin Resistance Adn Gene Expression in Muscle Cells in Healthy Overweight Women
  ClinicalTrials.gov Identifier: NCT00145392 - Active, not recruiting
  Obesity; Type 2 Diabetes; Polycystic Ovary Syndrome
  
• Empowering Patients to Better Manage Diabetes Through Self-Care
  ClinicalTrials.gov Identifier: NCT00254501 - Recruiting
  Type I or Type II Diabetes (Excludes Gestational Diabetes)
  
• Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
  ClinicalTrials.gov Identifier: NCT00133809 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• 4 Weeks Treatment of Type II Diabetic Patients With BI 44847
  ClinicalTrials.gov Identifier: NCT00558909 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00344370 - Active, not recruiting
  Type II Diabetes Mellitus; Dyslipidemia
  
• Rosiglitazone to Reverse Metabolic Defects in Diabetes
  ClinicalTrials.gov Identifier: NCT00094796 - Active, not recruiting
  Diabetes Mellitus, Type II; Insulin Resistance
  
• Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00309751 - Active, not recruiting
  Type II Diabetes Mellitus; Dyslipidemia
  
• Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00308737 - Active, not recruiting
  Diabetes Mellitus, Type I; Diabetes Mellitus, Type II
  
• Environmental Exposure to Lead and Progressive Renal Insufficiency in Type II Diabetic Nephropathy
  ClinicalTrials.gov Identifier: NCT00237952 - Recruiting
  Diabetic Nephropathies; Diabetes Mellitus, Type II
  
• Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY)
  ClinicalTrials.gov Identifier: NCT00081328 - Recruiting
  Diabetes Mellitus, Type II
  
• Effects of Vitamin B1 in Type 1 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00117026 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Phase II Randomized Study of three Different Schedules of Low-Dose Decitabine in Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00067808 - Active, not recruiting
  Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia
  
• Study In People With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00196989 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Carperitide in Acute Respiratory Distress Syndrome (ARDS)
  ClinicalTrials.gov Identifier: NCT00030121 - Active, not recruiting
  Respiratory Distress Syndrome
  
• Markers and Mechanisms of Vascular Disease in Type II Diabetes
  ClinicalTrials.gov Identifier: NCT00256646 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Family Management of Type 1 Diabetes in Children
  ClinicalTrials.gov Identifier: NCT00273286 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Diabetes Mellitus Type II and Tissue Oxygenation
  ClinicalTrials.gov Identifier: NCT00554697 - Active, not recruiting
  Diabetes Mellitus, Type II
  
• Amifostine in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003048 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome
  
• Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
  ClinicalTrials.gov Identifier: NCT00109772 - Completed
  Complex Regional Pain Syndrome, Type I
  
• Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003984 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; de novo myelodysplastic syndrome; ...
  
• A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00251511 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Prospective Randomized Trials of Gastric Bypass Surgery in Patients With Type II Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00540462 - Recruiting
  Type II Diabetes Mellitus
  
• A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1
  ClinicalTrials.gov Identifier: NCT00166452 - Recruiting
  Complex Regional Pain Syndrome, Type 1
  
• Study of the Safety and Efficacy of CC-5013 Treatment For Patients with Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00044382 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Comparing Surgical to Conservative Management in the Treatment of Type II Odontoid Fractures Among the Elderly
  ClinicalTrials.gov Identifier: NCT00283998 - Recruiting
  Odontoid Fractures Type II
  
• Phase II Gleevec Idiopathic Hypereosinophilic Syndrome
  ClinicalTrials.gov Identifier: NCT00230334 - Active, not recruiting
  Eosinophilia; Hypereosinophilic Syndrome
  
• Long-term Study of Starlix+Diovan to Delay Type II Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00097786 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00436475 - Recruiting
  Glucose Intolerance; Type 2 Diabetes Mellitus; Metabolic Syndrome
  
• Study of High-dose Pulse Administration DN-101 (Calcitriol) in Patients with Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00057031 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Renin Angiotensin System Study (RASS/B-RASS)
  ClinicalTrials.gov Identifier: NCT00143949 - Active, not recruiting
  Type 1 Diabetes
  
• Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00030589 - Active, not recruiting
  stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
  
• Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy and Pharmacokinetics of Myozyme in Patients with Late-Onset Pompe Disease.
  ClinicalTrials.gov Identifier: NCT00158600 - Active, not recruiting
  Pompe Disease (Late-onset); Glycogen storage disease type II (GSD-II); Acid Maltase Deficiency Disease; Glycogenosis 2
  
• A Randomized, Controlled Study on Ca Blocker Vs. AII Antagonists in Hypertension with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00144144 - Active, not recruiting
  Hypertension; Diabetes Mellitus, Type 2
  
• Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome
  ClinicalTrials.gov Identifier: NCT00068913 - Active, not recruiting
  MELAS Syndrome
  
• Amifostine With or Without Epoetin alfa in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003681 - Active, not recruiting
  Refractory Anemia; Previously Treated Myelodysplastic Syndrome; Anemia; secondary myelodysplastic syndrome; ...
  
• Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00140244 - Active, not recruiting
  HAART-induced lipodystrophy and metabolic syndrome
  
• A Study of the Efficacy and Safety of Genz-112638 in Type 1 Gaucher Patients
  ClinicalTrials.gov Identifier: NCT00358150 - Active, not recruiting
  Gaucher Disease, Type 1; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
  
• Acitretin in Treating Patients With Skin Disease or Skin Cancer
  ClinicalTrials.gov Identifier: NCT00020956 - Active, not recruiting
  actinic keratosis; stage III mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; skin metastases; ...
  
• Retrovirus Epidemiology Donor Study-II (REDS-II)
  ClinicalTrials.gov Identifier: NCT00097006 - Active, not recruiting
  Acquired Immunodeficiency Syndrome; Blood donors; Blood Transfusion; HIV Infections; HIV-1; HIV-2; HTLV-I; HTLV-II; Retroviridae Infections; ...
  
• Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
  ClinicalTrials.gov Identifier: NCT00074087 - Recruiting
  stage II mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; recurrent mycosis fungoides/Sezary syndrome; ...
  
• Oxandrolone Compared With a Placebo on Growth Rate in Girls With Growth Hormone-Treated Turner's Syndrome
  ClinicalTrials.gov Identifier: NCT00004275 - Active, not recruiting
  Turner's Syndrome
  
• Post-Marketing Safety Study of GSK Biological''s Pediarix™ Vaccine.
  ClinicalTrials.gov Identifier: NCT00146835 - Active, not recruiting
  Prophylaxis: Diphtheria, tetanus, pertussis, hepatitis B, poliovirus type 1, type 2 and type 3
  
• A Pilot Theraputic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients
  ClinicalTrials.gov Identifier: NCT00568802 - Active, not recruiting
  Muscular Atrophy, Spinal
  
• Evaluation of Effect of Exercise on Prescription
  ClinicalTrials.gov Identifier: NCT00399997 - Active, not recruiting
  Metabolic Syndrome X; Diabetes Mellitus, Type 2; Cardiovascular Diseases
  
• Retraining Walking after Spinal Cord Injury
  ClinicalTrials.gov Identifier: NCT00059553 - Active, not recruiting
  Spinal Cord Injuries; Quadriplegia; Paraplegia; Central Cord Syndrome; Brown-Sequard Syndrome
  
• Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
  ClinicalTrials.gov Identifier: NCT00364858 - Active, not recruiting
  Gaucher Disease, Type 1; Cerebroside Lipidosis Syndrome; Glucocerebrosidase Deficiency Disease; Glucosylceramide Beta-Glucosidase Deficiency Disease; Gaucher Disease, Non-Neuronopathic Form
  
• Low Dose Decitabine (DAC) in Myelodysplastic Syndrome (MDS) Post Azacytidine Failure
  ClinicalTrials.gov Identifier: NCT00113321 - Recruiting
  Myelodysplastic Syndrome
  
• Insulin Resistance and Testosterone in Women with Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00123110 - Recruiting
  Metabolic Syndrome; Postmenopause
  
• Efficacy and Safety In Poorly Controlled Type 2 Diabetics
  ClinicalTrials.gov Identifier: NCT00044460 - Active, not recruiting
  type 2 diabetes
  
• A Study to Assess SOM230 in Patients with Pituitary Cushing's Disease
  ClinicalTrials.gov Identifier: NCT00088608 - Active, not recruiting
  Cushing's Syndrome
  
• Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00005665 - Active, not recruiting
  Diabetes Mellitus, Type 1
  
• Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases
  ClinicalTrials.gov Identifier: NCT00003662 - Active, not recruiting
  Graft Versus Host Disease; Refractory Anemia; Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; ...
  
• Genetic and Clinical Study of Patients With Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
  ClinicalTrials.gov Identifier: NCT00004044 - Recruiting
  Head and Neck Cancer; Intraocular Melanoma; Melanoma (Skin); Non-Melanomatous Skin Cancer; Precancerous/Nonmalignant Condition
  
• Testosterone Therapy in Men With Low Testosterone Levels and Metabolic Syndrome or Early Stages of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00479609 - Recruiting
  Metabolic Syndrome
  
• Free Fatty Acids and Vascular Function in Subjects with Diabetes
  ClinicalTrials.gov Identifier: NCT00153179 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• O(6)-benzylguanine and Carmustine in Treating Patients With Stage I or Stage II Cutaneous T-cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00003613 - Active, not recruiting
  stage I cutaneous T-cell lymphoma; stage II cutaneous T-cell lymphoma; recurrent cutaneous T-cell lymphoma; stage I mycosis fungoides/Sezary syndrome; ...
  
• Effects of Colesevelam on How the Body Responds to Insulin in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00147745 - Recruiting
  Type 2 Diabetes
  
• Ultraviolet Light Therapy Using Methoxsalen With or Without Bexarotene in Treating Patients With Mycosis Fungoides
  ClinicalTrials.gov Identifier: NCT00056056 - Recruiting
  stage I mycosis fungoides/Sezary syndrome; stage II mycosis fungoides/Sezary syndrome; recurrent mycosis fungoides/Sezary syndrome
  
• Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00577590 - Recruiting
  Diabetes Mellitus, Type II
  
• The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized Study
  ClinicalTrials.gov Identifier: NCT00547482 - Recruiting
  Type 2 Diabetes Mellitus; Overweight
  
• Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome
  ClinicalTrials.gov Identifier: NCT00004347 - Recruiting
  Smith-Lemli-Opitz Syndrome
  
• Study of CRx-401 on Glucose Levels in Subjects With Type II Diabetes
  ClinicalTrials.gov Identifier: NCT00506298 - Recruiting
  Type 2 Diabetes
  
• MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)
  ClinicalTrials.gov Identifier: NCT00157729 - Completed
  Diabetes Mellitus Type 2; Hypertension; Metabolic Syndrome
  
• The Use of Drugs to Improve Kidney Function in Patients With Liver and Kidney Dysfunction
  ClinicalTrials.gov Identifier: NCT00240045 - Completed
  Type 2 Hepatorenal Syndrome; Refractory Ascites
  
• Topotecan in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003675 - Active, not recruiting
  Refractory Anemia; secondary myelodysplastic syndrome; refractory anemia with ringed sideroblasts; de novo myelodysplastic syndrome; ...
  
• Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients with Mild to Moderate Alzheimer's Disease (AD)
  ClinicalTrials.gov Identifier: NCT00104273 - Active, not recruiting
  Dementia, Alzheimer Type
  
• Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00008151 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
  
• Clofarabine alone versus Clofarabine in Combination with Low-Dose Cytarabine (ara-C) in Previously Untreated Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
  ClinicalTrials.gov Identifier: NCT00088218 - Active, not recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndrome
  
• Decitabine in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003361 - Active, not recruiting
  de novo myelodysplastic syndrome; refractory anemia with excess blasts in transformation; refractory anemia with excess blasts; Refractory Anemia; ...
  
• Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
  ClinicalTrials.gov Identifier: NCT00010387 - Active, not recruiting
  Anemia, Hemolytic, Autoimmune; Felty Syndrome; Purpura, Thrombocytopenic; Autoimmune Diseases
  
• Late-Onset Treatment Study Extension Protocol
  ClinicalTrials.gov Identifier: NCT00455195 - Active, not recruiting
  Pompe Disease (Late-Onset); Glycogen Storage Disease Type II (GSD-II); Glycogenesis 2; Acid Maltase Deficiency
  
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• Rituximab to Treat Stiff Person Syndrome
  ClinicalTrials.gov Identifier: NCT00091897 - Active, not recruiting
  Stiff Person Syndrome
  
• Diet, Obesity and Genes (DiOGenes)
  ClinicalTrials.gov Identifier: NCT00390637 - Active, not recruiting
  Obesity; Metabolic Syndrome; Type 2 Diabetes; Cardiovascular Disease
  
• A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCCs With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome
  ClinicalTrials.gov Identifier: NCT00500643 - Recruiting
  Basal Cell Carcinomas; Gorlin Syndrome; Basal Cell Nevus Syndrome
  
• Effects of an Intensified Treatment With ACE-I,ATA II and Statins in Alport Syndrome
  ClinicalTrials.gov Identifier: NCT00309257 - Recruiting
  Alport Syndrome
  
• Study of Individuals with Parkinson''s Symptoms But in Whom There is Diagnostic Uncertainty
  ClinicalTrials.gov Identifier: NCT00129675 - Recruiting
  Parkinsonian Syndrome
  
• Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00003415 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; de novo myelodysplastic syndrome; refractory anemia with excess blasts in transformation; ...
  
• Safety and Efficacy of an Investigational Drug in HIV-infected Patients Failing Current Antiretroviral Therapies
  ClinicalTrials.gov Identifier: NCT00105157 - Active, not recruiting
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00532506 - Recruiting
  Type 2 Diabetes Mellitus
  
• A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients
  ClinicalTrials.gov Identifier: NCT00100048 - Active, not recruiting
  HIV Infections; Acquired Immunodeficiency Syndrome
  
• PKC412 in Patients with Acute Myeloid Leukemia and Patients with Myelodysplastic Syndrome with either Wild Type or Mutated FLT3
  ClinicalTrials.gov Identifier: NCT00045942 - Active, not recruiting
  Acute Myeloid Leukemia; Myelodysplastic Syndromes
  
• Dose Finding Study to Assess the Efficacy & Safety of Dysport in Upper Back Myofascial Pain Syndrome
  ClinicalTrials.gov Identifier: NCT00134810 - Completed
  Myofascial Pain Syndrome
  
• Study of TNF-Antagonism in the Metabolic Syndrome (II)
  ClinicalTrials.gov Identifier: NCT00413400 - Recruiting
  Metabolic Syndrome
  
• Type II Supracondylar Fractures in Children
  ClinicalTrials.gov Identifier: NCT00207870 - Recruiting
  Type II Supracondylar Fractures
  
• Internet Diabetes Self-Management
  ClinicalTrials.gov Identifier: NCT00185601 - Active, not recruiting
  diabetes type 2
  
• Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on
  ClinicalTrials.gov Identifier: NCT00350779 - Active, not recruiting
  Diabetes Mellitus, Type II
  
• Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia
  ClinicalTrials.gov Identifier: NCT00005937 - Active, not recruiting
  Myelodysplastic Syndrome
  
• Restless Legs Syndrome Exercise Intervention
  ClinicalTrials.gov Identifier: NCT00258492 - Active, not recruiting
  Restless Legs Syndrome; Insomnia; Daytime Sleepiness
  
• An Investigational Drug in Patients with Type 2 Diabetes Mellitus and Chronic Renal Insufficiency
  ClinicalTrials.gov Identifier: NCT00095056 - Active, not recruiting
  Diabetes Mellitus, Type 2; Chronic Renal Insufficiency
  
• Temozolomide in Treating Patients With Mycosis Fungoides or Sezary Syndrome
  ClinicalTrials.gov Identifier: NCT00004106 - Active, not recruiting
  Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
  
• Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
  ClinicalTrials.gov Identifier: NCT00110266 - Active, not recruiting
  Myelodysplastic Syndrome; Iron Overload
  
• Long-Term Study of Safety and Efficacy of WelChol® as an Additional Therapy in Patients with Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00151762 - Active, not recruiting
  Type 2 Diabetes
  
• Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag
  ClinicalTrials.gov Identifier: NCT00097474 - Active, not recruiting
  Jet Lag Syndrome
  
• ANN-Study: Amaryl, Novorapid, Novomix Study
  ClinicalTrials.gov Identifier: NCT00151697 - Recruiting
  diabetes mellitus type II
  
• Mechanisms of Ramipril Reduction in the Onset of Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00574834 - Recruiting
  Metabolic Syndrome
  
• Oral Type I Collagen for Relieving Scleroderma
  ClinicalTrials.gov Identifier: NCT00005675 - Active, not recruiting
  Scleroderma; Connective Tissue Diseases